about
Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancerInvasive Bladder Cancer: Genomic Insights and Therapeutic PromiseNaturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs.Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosisInoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine ModelThe timing of caffeic acid treatment with cisplatin determines sensitization or resistance of ovarian carcinoma cell lines.Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine.High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer.Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets.Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee.Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma.
P2860
Q28076041-761203F3-2FBF-46F8-9B3A-47B81D8B4E9FQ28088334-B6362B29-5D62-4463-9CD6-665AFCCDB795Q33593041-D1B092BF-2B5B-46B6-81CE-1F65D62025FCQ33817493-05C74102-EA46-4C93-8918-DCC7CEE787B1Q36184480-78AA9D51-41BA-4EED-AA36-52C113275E9AQ37496947-8E1FE6E4-047B-406A-9A4B-0C199F637281Q37555069-26037062-3556-4953-B7C6-541BFD012EE9Q37723023-A91F0892-BD92-49CD-B99C-6634F559B39BQ39432577-6A01B288-A0E6-4219-BEF7-CA107D7F9256Q39861038-4A3C02CF-C509-4329-AD5A-77B05061A317Q54966706-195B0EC1-1BFC-49E3-A22F-0B97F385C54F
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Optimal treatment for metastatic bladder cancer.
@en
type
label
Optimal treatment for metastatic bladder cancer.
@en
prefLabel
Optimal treatment for metastatic bladder cancer.
@en
P2860
P1476
Optimal treatment for metastatic bladder cancer.
@en
P2093
Estrella M Carballido
P2860
P2888
P356
10.1007/S11912-014-0404-2
P577
2014-09-01T00:00:00Z
P6179
1008851303